Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

101.87 -0.01 (-0.01%)
Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
94 95 Next >
Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
Investors are busy looking at tech stocks, but they should be looking for healthcare stocks to buy, as this group powers to new highs. 
Via InvestorPlace
Immutep Shares Spike As Cancer Tratement Shows Favorable Results In Phase 2 Trial
Immutep Limited's (NASDAQ: IMMP) lead candidate — a soluble LAG-3 protein, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) — 
Via Benzinga
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
In a rare move to block a large pharma deal, the U.S. 
Via Benzinga
Merck to Present Extensive New Research Demonstrating Significant Progress in the Treatment of Certain Earlier Stage Cancers and in Advancing Broad Oncology Pipeline at 2023 ASCO Annual Meeting
From Merck & Co., Inc.
Via Business Wire
Looking At Merck & Co's Recent Unusual Options Activity
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
Check Out What Whales Are Doing With MRK
Via Benzinga
3 Penny Stocks That Could Make You a Millionaire by 2025
These are the best penny stocks to buy if you are targeting multibagger returns by 2025 with high price targets by analysts. 
Via InvestorPlace
The 3 Best MedTech Stocks to Watch in May 2023
Here's a look at the best MedTech stocks to watch in May, which include Teladoc, Veeva and iRhythms Technology. 
Via InvestorPlace
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
Via Benzinga
Where Merck & Co Stands With Analysts
Via Benzinga
Merck (MRK) Q1 2023 Earnings Call Transcript
MRK earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Can You Still Buy the Dow Jones' Best-Performing April Stocks?
It helps to look at the bigger picture first and foremost and weigh companies' long-term staying power. 
Via The Motley Fool
Pharma ETFs Gain Post Q1 Earnings
Pharma ETFs have been in the green over the past month. 
Via Talk Markets
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street. 
Via Benzinga
2 Top Healthcare Stocks Defying the Bear Market
These pharmaceutical companies are expected to see a big rise in revenue, thanks to new therapies. 
Via The Motley Fool
7 Hot Growth Stocks Poised to Triple in 2023
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher. 
Via InvestorPlace
The Next Evolution In Drugs? It's Artificial Intelligence, Says This CEO
This company is hoping to execute for a second time on its moonshot goal. 
Via Investor's Business Daily
3 Underperforming Nasdaq 100 Stocks Worth a Closer Look
Given the volatility and growth potential associated with the Nasdaq’s elite, investors may want to keep these recent underperformers on the watch list. 
Via MarketBeat
Topics Stocks
Exposures US Equities
What's Going On With Immix Biopharma Stock Today
Immix Biopharma Inc (NASDAQ: IMMX) announced early interim data from IMMINENT-01 Phase 1b/2a trial combining tissue-specific therapeutic IMX-110 with BeiGene Ltd (NYSE: BGNE) / Novartis AG' 
Via Benzinga
Insurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case
A New Jersey appellate court ruled that a group of insurers can’t use war as an argument to deny Merck & Co Inc (NYSE: MRK) coverage from the $1.4 billion cyberattack that happened in 2017. 
Via Benzinga
Merck to Participate in Bank of America Securities 2023 Healthcare Conference
From Merck & Co., Inc.
Via Business Wire
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
Can-Fite BioPharma Ltd. (NYSEAMERICAN: CANF) is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers 
Via MarketBeat
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust. 
Via MarketBeat
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
From Brodsky & Smith LLC
Via GlobeNewswire
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
Via Benzinga
Update on FDA Advisory Committee Vote on LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer
From Merck & Co., Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies. 
Via Investor's Business Daily
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
94 95 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.